Aarey Drugs & Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, to the BSE Limited and the National Stock Exchange of India Limited. This certificate pertains to the quarter ended December 31, 2025.

The company received this confirmation from its Registrar and Share Transfer Agent, M/s. MUFG Intime India Private Limited. The certificate confirms that securities received from depository participants for dematerialization during the specified quarter were processed and confirmed with the depositories. It also states that the securities were listed on the stock exchanges where the company's existing securities are listed. Furthermore, the registrar confirmed that the security certificates received for dematerialization were duly verified, mutilated, cancelled, and the names of the depositories were substituted in the register of members within the prescribed timelines.

This submission is a routine compliance filing related to share transfer and dematerialization processes.